Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Bowel Cancer Awareness Month Starts Today

Bowel Cancer Australia < 1 mins read

Bowel Cancer Awareness Month Starts Today!

 

Bowel Cancer Australia’s signature event raising awareness of Australia's second deadliest cancer and funds for the 100% community-funded national charity.

 

Bowel Cancer Australia is dedicated to championing what matters most to people impacted by bowel cancer and empowering everyone affected to live their best life.

 

    • 1-in-14 Australians will be diagnosed with bowel cancer in their lifetime 

    • 15,531 people are diagnosed with bowel cancer each year (299 a week) 

    • Bowel cancer claims the lives of 5,354 people every year (103 a week) 

    • 1-in-9 new bowel cancer cases diagnosed in people under age 50 (1,716 a year) 

    • Almost 99% of bowel cancer cases can be successfully treated, when detected early 

bowelcanceraustralia.org

Helpline: 1800 727 336 (SCREEN)

 


Contact details:


For an interview with a medical expert or patient contact:
Stephanie Bansemer-Brown – Bowel Cancer Australia
stephanie@bowelcanceraustralia.org   |   0412 915 797

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.